155 related articles for article (PubMed ID: 10868688)
1. Genetic polymorphisms of N-acetyltransferases 1 and 2 and gene-gene interaction in the susceptibility to childhood acute lymphoblastic leukemia.
Krajinovic M; Richer C; Sinnett H; Labuda D; Sinnett D
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):557-62. PubMed ID: 10868688
[TBL] [Abstract][Full Text] [Related]
2. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594
[TBL] [Abstract][Full Text] [Related]
3. Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10.
Cascorbi I; Roots I; Brockmöller J
Cancer Res; 2001 Jul; 61(13):5051-6. PubMed ID: 11431340
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia.
Canalle R; Burim RV; Tone LG; Takahashi CS
Environ Mol Mutagen; 2004; 43(2):100-9. PubMed ID: 14991750
[TBL] [Abstract][Full Text] [Related]
5. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer.
Bell DA; Stephens EA; Castranio T; Umbach DM; Watson M; Deakin M; Elder J; Hendrickse C; Duncan H; Strange RC
Cancer Res; 1995 Aug; 55(16):3537-42. PubMed ID: 7627961
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.
Hein DW; Doll MA; Fretland AJ; Leff MA; Webb SJ; Xiao GH; Devanaboyina US; Nangju NA; Feng Y
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):29-42. PubMed ID: 10667461
[TBL] [Abstract][Full Text] [Related]
7. [Genetic polymorphism in GST, NAT2, and MTRR and susceptibility to childhood acute leukemia].
Gra OA; Glotov AS; Kozhekbaeva Zhm; Makarova OV; Nasedkina TV
Mol Biol (Mosk); 2008; 42(2):214-25. PubMed ID: 18610829
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia.
Krajinovic M; Labuda D; Mathonnet G; Labuda M; Moghrabi A; Champagne J; Sinnett D
Clin Cancer Res; 2002 Mar; 8(3):802-10. PubMed ID: 11895912
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer.
Hsieh FI; Pu YS; Chern HD; Hsu LI; Chiou HY; Chen CJ
Br J Cancer; 1999 Oct; 81(3):537-41. PubMed ID: 10507782
[TBL] [Abstract][Full Text] [Related]
10. Genetic susceptibility to childhood acute lymphoblastic leukemia.
Sinnett D; Krajinovic M; Labuda D
Leuk Lymphoma; 2000 Aug; 38(5-6):447-62. PubMed ID: 10953966
[TBL] [Abstract][Full Text] [Related]
11. Para-phenylenediamine and allergic sensitization: risk modification by N-acetyltransferase 1 and 2 genotypes.
Blömeke B; Brans R; Coenraads PJ; Dickel H; Bruckner T; Hein DW; Heesen M; Merk HF; Kawakubo Y
Br J Dermatol; 2009 Nov; 161(5):1130-5. PubMed ID: 19663877
[TBL] [Abstract][Full Text] [Related]
12. 'Comparison of extremes' approach provides evidence against the modifying role of NAT2 polymorphism in lung cancer susceptibility.
Belogubova EV; Kuligina ESh; Togo AV; Karpova MB; Ulibina JM; Shutkin VA; Hanson KP; Popowski K; Mosyagin I; Cascorbi I; Hirvonen A; Imyanitov EN
Cancer Lett; 2005 Apr; 221(2):177-83. PubMed ID: 15808403
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children.
Joseph T; Kusumakumary P; Chacko P; Abraham A; Radhakrishna Pillai M
Pediatr Blood Cancer; 2004 Oct; 43(5):560-7. PubMed ID: 15382273
[TBL] [Abstract][Full Text] [Related]
14. N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer.
Alberg AJ; Daudt A; Huang HY; Hoffman SC; Comstock GW; Helzlsouer KJ; Strickland PT; Bell DA
Cancer Detect Prev; 2004; 28(3):187-93. PubMed ID: 15225898
[TBL] [Abstract][Full Text] [Related]
15. Association of arylamine N-acetyltransferases NAT1 and NAT2 genotypes to laryngeal cancer risk.
Henning S; Cascorbi I; Münchow B; Jahnke V; Roots I
Pharmacogenetics; 1999 Feb; 9(1):103-11. PubMed ID: 10208649
[TBL] [Abstract][Full Text] [Related]
16. Association of arylamine N-acetyltransferase (NAT1 and NAT2) genotypes with urinary bladder cancer risk.
Jaskuła-Sztul R; Sokołowski W; Gajecka M; Szyfter K
J Appl Genet; 2001; 42(2):223-31. PubMed ID: 14564055
[TBL] [Abstract][Full Text] [Related]
17. Association of NAT and GST polymorphisms with non-Hodgkin's lymphoma: a population-based case-control study.
Chiu BC; Kolar C; Gapstur SM; Lawson T; Anderson JR; Weisenburger DD
Br J Haematol; 2005 Mar; 128(5):610-5. PubMed ID: 15725081
[TBL] [Abstract][Full Text] [Related]
18. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698
[TBL] [Abstract][Full Text] [Related]
19. N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk.
Bouchardy C; Mitrunen K; Wikman H; Husgafvel-Pursiainen K; Dayer P; Benhamou S; Hirvonen A
Pharmacogenetics; 1998 Aug; 8(4):291-8. PubMed ID: 9731715
[TBL] [Abstract][Full Text] [Related]
20. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults.
Gemmati D; Ongaro A; Scapoli GL; Della Porta M; Tognazzo S; Serino ML; Di Bona E; Rodeghiero F; Gilli G; Reverberi R; Caruso A; Pasello M; Pellati A; De Mattei M
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):787-94. PubMed ID: 15159311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]